# FDA 483 - United Exchange Corp. - April 06, 2018

Source: https://www.globalkeysolutions.net/records/483/united-exchange-corp/db5e07f0-748d-42e6-b6fd-0e5afa6f7952

> FDA 483 for United Exchange Corp. on April 06, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: United Exchange Corp.
- Inspection Date: 2018-04-06
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations IV
- Summary: An FDA inspection of United Exchange Corp., a pharmaceutical warehouse and importer in Rialto, CA, revealed two significant observations. The firm's sampling plan for incoming drug products was found to be unrepresentative and samples were not properly identified. Additionally, the facility lacked adequate segregation and identification methods for quarantined drug products, storing them alongside released products.

## Related Officers

- [Zachary A. Bogorad](https://www.globalkeysolutions.net/people/zachary-a-bogorad/ae582dcd-f893-44a5-98bd-0b55f401577b)

Company: https://www.globalkeysolutions.net/companies/united-exchange-corp/13fa0a23-b7b9-494a-8f81-a91a9fa8c52b

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6